JAMA · 2017
Screening for Celiac Disease: US Preventive Services Task Force Recommendation Statement.
СтатьяКлинические рекомендацииПоддержка службы здравоохранения СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
US Preventive Services Task Force, Bibbins-Domingo Kirsten, Grossman David C, Curry Susan J, Barry Michael J, Davidson Karina W, Doubeni Chyke A, Ebell Mark, Epling John W, Herzstein Jessica, Kemper Alex R, Krist Alex H, Kurth Ann E, Landefeld C Seth, Mangione Carol M, Phipps Maureen G, Silverstein Michael, Simon Melissa A, Tseng Chien-Wen
Аннотация
IMPORTANCE: Celiac disease is caused by an immune response in persons who are genetically susceptible to dietary gluten, a protein complex found in wheat, rye, and barley. Ingestion of gluten by persons with celiac disease causes immune-mediated inflammatory damage to the small intestine.
OBJECTIVE: To issue a new US Preventive Services Task Force (USPSTF) recommendation on screening for celiac disease.
EVIDENCE REVIEW: The USPSTF reviewed the evidence on the accuracy of screening in asymptomatic adults, adolescents, and children; the potential benefits and harms of screening vs not screening and targeted vs universal screening; and the benefits and harms of treatment of screen-detected celiac disease. The USPSTF also reviewed contextual information on the prevalence of celiac disease among patients without obvious symptoms and the natural history of subclinical celiac disease.
FINDINGS: The USPSTF found inadequate evidence on the accuracy of screening for celiac disease, the potential benefits and harms of screening vs not screening or targeted vs universal screening, and the potential benefits and harms of treatment of screen-detected celiac disease.
CONCLUSIONS AND RECOMMENDATION: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons. (I statement).
OBJECTIVE: To issue a new US Preventive Services Task Force (USPSTF) recommendation on screening for celiac disease.
EVIDENCE REVIEW: The USPSTF reviewed the evidence on the accuracy of screening in asymptomatic adults, adolescents, and children; the potential benefits and harms of screening vs not screening and targeted vs universal screening; and the benefits and harms of treatment of screen-detected celiac disease. The USPSTF also reviewed contextual information on the prevalence of celiac disease among patients without obvious symptoms and the natural history of subclinical celiac disease.
FINDINGS: The USPSTF found inadequate evidence on the accuracy of screening for celiac disease, the potential benefits and harms of screening vs not screening or targeted vs universal screening, and the potential benefits and harms of treatment of screen-detected celiac disease.
CONCLUSIONS AND RECOMMENDATION: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons. (I statement).